William Tillett is a pharmacist who is specialized in Oncology in Brunswick, Georgia. Patients can reach him at 2500 Starling St Ste 303, Brunswick or contact him on 912-466-5363. Active license number of William Tillett is RPH014541 for Oncology in Georgia. William Tillett is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
William Tillett speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
William Tillett
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
2500 Starling St Ste 303, Brunswick, Georgia, 31520-4268
Phone:
912-466-5363
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of William Tillett are as mentioned below.
NPI Number:
1316517857
NPI Enumeration Date:
28 Jun, 2021
NPI Last Update On:
28 Jun, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for William Tillett are as mentioned below.
Specialization
License Number
State
Status
Oncology
RPH014541
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2500 Starling St Ste 303, Brunswick, Georgia
Zip:
31520-4268
Phone Number:
912-466-5363
Fax Number:
--
Patients can reach William Tillett at 2500 Starling St Ste 303, Brunswick, Georgia or can call on phone at 912-466-5363.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.